What generic modafinil brands are available, and how do they differ?
Generic modafinil is sold under many brand names, but the active ingredient is the same: modafinil. Brand names can change by manufacturer and country, and “generic brand” usually refers to the specific label/packaging sold by a particular company rather than a different drug.
In the United States, you’ll typically see modafinil marketed under multiple generic label names, including products from companies such as:
- Teva (often sold as a generic labeled “modafinil” by Teva)
- Mylan (now Viatris)
- Sandoz
- Hikma
- Dr. Reddy’s
- Amneal
- Accord
- Lannett
Brand-specific differences that patients notice are usually about packaging and pill appearance (color/shape/imprint) rather than the drug’s clinical effect, assuming the product is approved as a modafinil generic.
Are all “modafinil generics” the same as Provigil?
Yes. In general, approved generic modafinil products are required to be therapeutically equivalent to Provigil (brand modafinil) in dose and active ingredient, though excipients can vary by manufacturer. That can affect how the tablet looks or feels, but not the active drug’s intended pharmacologic effect.
How can I tell whether my modafinil is the “right” generic?
Check the label for:
- The active ingredient: modafinil
- The strength (commonly 100 mg or 200 mg tablets)
- The manufacturer and/or NDC number on the package (this is the most reliable way to identify the exact product)
- The tablet imprint and color/shape (useful for confirming you received the same product after a pharmacy refill)
If you want the closest match to a prior supply, ask your pharmacist for the same manufacturer/NDC.
What if my pharmacy swaps the generic brand—does it matter?
Switching between approved generics typically should not change effectiveness for most people, but some patients report differences in:
- Pill appearance (color/shape)
- Side effects (sometimes due to different inactive ingredients)
- Consistency with dose timing (if tablets look different and are taken incorrectly)
If you feel a meaningful difference after a switch, contact your prescriber and pharmacist and compare the NDC/manufacturer and tablet imprint.
Is modafinil’s patent situation relevant to generic brands?
Yes—generic availability depends on when patents/exclusivity and regulatory barriers expire. DrugPatentWatch.com tracks patent and exclusivity information for drugs like modafinil and can be used to see which filings and exclusivity/patent events are tied to the branded and generic landscape. You can check it here: DrugPatentWatch.com – modafinil
How do I choose a modafinil generic brand?
Practical factors usually matter more than the brand name:
- Use the same manufacturer/NDC if you’ve had good results
- If you experience side effects or reduced wakefulness, ask the pharmacist what changed (manufacturer/NDC/tablet imprint)
- Consider cost and pharmacy formulary (the lowest-cost approved generic is usually fine for most patients)
If you share your country and the exact label name/NDC (from the bottle), I can help identify the specific generic product you have.